Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival

Precise assessment of treatment response in glioblastoma during combined anti-angiogenic and chemoradiation remains a challenge. In particular, early detection of treatment response by standard anatomical imaging is confounded by pseudo-response or pseudo-progression. Metabolic changes may be more s...

Descripción completa

Detalles Bibliográficos
Autores principales: Andronesi, Ovidiu C., Esmaeili, Morteza, Borra, Ronald J. H., Emblem, Kyrre, Gerstner, Elizabeth R., Pinho, Marco C., Plotkin, Scott R., Chi, Andrew S., Eichler, April F., Dietrich, Jorg, Ivy, S. Percy, Wen, Patrick Y., Duda, Dan G., Jain, Rakesh, Rosen, Bruce R., Sorensen, Gregory A., Batchelor, Tracy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708878/
https://www.ncbi.nlm.nih.gov/pubmed/29202103
http://dx.doi.org/10.1038/s41698-017-0020-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708878/
https://www.ncbi.nlm.nih.gov/pubmed/29202103
http://dx.doi.org/10.1038/s41698-017-0020-3

Ejemplares similares